Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM197 in United States infants

Pediatrics

Volumn 101, Issue 4 I, 1998, Pages 604-611

  Rennels, Margaret B ^a,h   Edwards, Kathryn M ^b   Keyserling, Harry L ^c   Reisinger, Keith S ^d   Hogerman, Deborah A ^e   Madore, Dace V ^f,g   Chang, Ih ^e   Paradiso, Peter R ^e   Malinoski, Frank J ^f,g   Kimura, Alan ^e  

^a University of Maryland School of Medicine Center for Vaccine Development   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NIOSH Pittsburgh Research Laboratory   (United States)

^e PFIZER INC   (United States)

^f NABI ^*

^g Nabi Biopharmaceuticals   (United States)

^h University Hospital Bern   (United States)

Author keywords

Pediatric; Pneumococcal; Vaccine

Indexed keywords

CROSS REACTING ANTIGEN; DIPHTHERIA PERTUSSIS TETANUS HAEMOPHILUS INFLUENZAE TYPE B VACCINE; MEASLES MUMPS RUBELLA VACCINE; MENINGOCOCCUS VACCINE; ORAL POLIOMYELITIS VACCINE; PNEUMOCOCCUS VACCINE;

ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; HUMAN; HUMAN EXPERIMENT; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; IMMUNOLOGICAL MEMORY; IMMUNOSURVEILLANCE; INFANT; INTRAMUSCULAR DRUG ADMINISTRATION; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; SEROTYPE; UNITED STATES; VACCINE PRODUCTION;

ANTIBODIES, BACTERIAL; BACTERIAL TYPING TECHNIQUES; BACTERIAL VACCINES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; IMMUNIZATION, SECONDARY; INFANT; MALE; MENINGOCOCCAL VACCINES; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; STREPTOCOCCUS PNEUMONIAE; UNITED STATES; VACCINES, CONJUGATE;

EID: 0031917702     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.101.4.604     Document Type: Article

References (23)

1. Adams WG, Deaver KA, Cochi SL, et al. Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era. JAMA. 1993; 269:221-226
2. Centers for Disease Control and Prevention. Progress toward elimination of Haemophilus influenzae type b disease among infants and children. MMWR. 1995;44:545-550
3. Breiman RF, Butler JC, Tenover FC, Elliot JA, Facklam RR. Emergence of drug-resistant pneumococcal infections in the United States. JAMA. 1994;271:1831-1835
4. Leggiadro RJ, Barrett FF, Chesney PJ, Davis Y, Tenover FC. Invasive pneumococci with high-level penicillin resistance at a children's hospital. Pediatr Infect Dis J. 1994;13:320-322
5. Duchin JS, Breiman RF, Diamond A, et al. High prevalence of multidrug-resistant Streptococcus pneumoniae among children in a rural Kentucky community. Pediatr Infect Dis J. 1995;14:745-750
6. Shapiro ED, Austrian R. Serotypes responsible for invasive Streptococcus pneumoniae infections among children in Connecticut. J Infect Dis. 1994; 169:212-214
7. Butler JC, Breiman RF, Lipman HB, Hofmann J, Facklam RR. Serotype distribution of Streptococcus pneumoniae infections among preschool children in the United States, 1978-1994: implications for development of a conjugate vaccine. J Infect Dis. 1995;171:885-889
8. Åhman H, Käyhty H, Tamminen P, Vuorela A, Malinoski F, Eskola J. Pentavalent pneumococcal oligosaccharide conjugate vaccine PncCRM is well-tolerated and able to induce an antibody response in infants. Pediatr Infect Dis J. 1996:15:134-139
9. Leach A, Ceesay SJ, Banya WAS, Greenwood BM. Pilot trial of a pentavalent pneumococcal polysaccharide/protein conjugate vaccine in Gambian infants. Pediatr Infect Dis J. 1996;15:333-339
10. 197 conjugate vaccines: effect of saccharide size on immunogenicity and interactions with simultaneously administered HbOC and DTP vaccines. J Infect Dis. 1997;176: 445-455
11. 197 vaccines. In: Abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy; September 17-20, 1996; San Francisco, CA: American Society for Microbiology; 1996:151
12. Käyhty H, Chman H, Vuorela A, Malinosky F, Eskola J. Response at 24 months to a booster dose of pneumococcal (Pnc) polysaccharide vaccine in children immunized with pentavalent Pnc conjugate vaccine (Pnc-CRM) in infancy. In: Abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy; September 17-20, 1996; San Francisco, CA: American Society for Microbiology; 1996:162
13. Lawrence EM, Edwards KM, Schiffman G, et al. Pneumococcal vaccine in normal children: primary and secondary vaccination. Am J Dis Child. 1983;137:846-850
14. Quataert SA, Kirch CS, Wiedl LJ, et al. Assignment of weight-based antibody units to a human antipneumococcal standard reference serum, lot 89-S. Clin Diagn Lab lmmunol. 1995;2:590-597
15. Reed GF, Meade BD, Steinhoff MC. The reverse cumulative distribution plot: a graphic method for exploratory analysis of antibody data. Pediatrics. 1995;96(suppl):600-603
16. Borgono IM, McLean AA, Vela PP, et al. Vaccination and revaccination with polyvalent pneumococcal polysaccharide vaccines in adults and infants. Proc Soc Exp Biol Med. 1978;157:148-154
17. Advisory Committee on Immunization Practices. Recommendations for use of Haemophilus b conjugate vaccines and a combined diphtheria, tetanus, pertussis, and Haemophilus b vaccine. MMWR. 1993;42:1-15
18. Käyhty H, Peltola H, Karanko V, Mäkelä PH. The protective level of serum antibodies to the capsular polysaccharide of H influenzae type b. J Infect Dis. 1983;147:1100
19. Ambrosino DM, Landesman SH, Gorham CG, Siber GR. Passive immunization against disease due to Haemophilus influenzas type b: concentration of antibody to capsular polysaccharide in high-risk children. J Infect Dis. 1986;153:1-7
20. Siber GR, Thompson C, Reid GR, et al. Evaluation of bacterial polysaccharide immune globulin for the treatment or prevention of Haemophilus influenzae type b and pneumococcal disease. J Infect Dis. 1992;165(suppl 1):S129-S133
21. Dagan R, Melamed R, Muallem M, et al. Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine. J Infect Dis. 1996;174:1271-1278
22. Lipsitch M. Vaccination against colonizing bacteria with multiple serotypes. Proc Natl Acad Sci USA. 1997;94:6571-6576
23. Barnes DM, Whitter S, Gilligan PH, Soares S, Tomaz A, Henderson FW. Transmission of multidrug-resistant serotype 23F Streptococcus pneumoniae in group day care: evidence suggesting capsular transformation of the resistant strain in vivo. J Infect Dis. 1995;171:890-896